Bruker Corporation (BRKR)

$58.25

up-down-arrow $-3.09 (-5.04%)

As on 07-Jul-2026 16:05EDT

Market cap

info icon

$9,383 Mln

Revenue (TTM)

info icon

$3,459 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

3.8

Div. Yield

info icon

0.3 %

Bruker (BRKR) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 57.65 High: 61.87

52 Week Range

Low: 28.53 High: 64.54

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    51.01

  • EV/EBITDAEV/EBITDA information

    35.6

  • Debt to EquityDebt to Equity information

    0.7

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.1

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    152,225,624

10 Years Aggregate

CFO

$2,309.50 Mln

EBITDA

$3,741.20 Mln

Net Profit

$1,926.10 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Bruker (BRKR)
23.6 3.3 58.5 37.2 -7.4 -5.7 9.8
BSE Sensex*
-8.1 4.8 4.3 -6.8 6.0 8.0 11.1
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 07-Jul-2026  |  *As on 08-Jul-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Bruker (BRKR)
-19.6 -20.1 7.5 -18.5 55.0 6.2 71.2
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Bruker (BRKR)
58.3 9,383.2 3,458.5 -11.6 2.2 -0.6 -- 3.8
37.8 4,952.6 638.8 -22.7 7.4 -2.8 -- 6.1
10.2 7,046.0 6,552.2 -551.4 -4.4 -9.9 -- 1.2
296.5 7,934.6 2,589.9 168.8 10.5 2.5 49.3 1.2
150.7 8,712.6 551.4 -189.3 -34.4 -26.3 -- 12.0
103.4 7,154.5 1,546.2 279.0 25.4 23.9 26.2 5.9
180.0 9,423.8 1,558.5 76.3 19.6 9.5 44.4 11.9
72.1 4,240.9 1,542.8 139.3 13.8 8.8 30.6 2.6
318.3 12,529.8 1,454.3 171.1 14.0 12.1 73.6 8.4
139.8 8,032.5 763.3 51.4 10.3 2.5 156.5 3.8

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Bruker (BRKR)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID,...  BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts. 

  • Chairman, CEO & President

    Dr. Frank H. Laukien Ph.D.

  • Chairman, CEO & President

    Dr. Frank H. Laukien Ph.D.

  • Headquarters

    Billerica, MA

  • Website

    https://www.bruker.com

Edit peer-selector-edit
loading...
loading...

FAQs for Bruker (BRKR)

The share price of Bruker Corporation (BRKR) is $58.25 (NASDAQ) as of 07-Jul-2026 16:05 EDT. Bruker Corporation (BRKR) has given a return of -7.41% in the last 3 years.

Since, TTM earnings of Bruker Corporation (BRKR) is negative, P/E ratio is not available.
The P/B ratio of Bruker Corporation (BRKR) is 3.83 times as on 02-Jul-2026, a 1 premium to its peers’ median range of 3.79 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-835.38
2.92
2024
78.78
5.00
2023
25.11
7.79
2022
34.08
9.08
2021
46.18
11.95

The 52-week high and low of Bruker Corporation (BRKR) are Rs 64.54 and Rs 28.53 as of 08-Jul-2026.

Bruker Corporation (BRKR) has a market capitalisation of $ 9,383 Mln as on 02-Jul-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Bruker Corporation (BRKR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.